ReviewFrontiers in nutrition2026

Metabolic dysfunction-associated steatotic liver disease and immune checkpoint inhibitor response in gastrointestinal liver metastases: current evidence and future directions.

Shilin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.